Trial Profile
Phase II study of the safety and efficacy of photodynamic therapy [porfimer sodium (Photofrin) + controlled uniform laser light] in carcinoma in situ of the esophagus.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Porfimer sodium (Primary)
- Indications Barrett's oesophagus; High-grade oesophageal dysplasia; Oesophageal cancer
- Focus Therapeutic Use
- 22 Dec 2011 Additional lead trial investigator (Hector R. Nava, MD, FACS) identified as reported by ClinicalTrials.gov.
- 22 Feb 2011 Actual end date (Sep 2007) added as reported by ClinicalTrials.gov.
- 22 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.